Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Mar 17;18(3):e0283352. doi: 10.1371/journal.pone.0283352

Clinical phenotypes of chronic cough categorised by cluster analysis

Jiyeon Kang 1, Woo Jung Seo 1, Jieun Kang 1, So Hee Park 1, Hyung Koo Kang 1, Hye Kyeong Park 1, Sung-Soon Lee 1, Ji-Yong Moon 2, Deog Kyeom Kim 3, Seung Hun Jang 4, Jin Woo Kim 5, Minseok Seo 6, Hyeon-Kyoung Koo 1,*
Editor: Bharat Bhushan Sharma7
PMCID: PMC10022767  PMID: 36930618

Abstract

Background

Chronic cough is a heterogeneous disease with various aetiologies that are difficult to determine. Our study aimed to categorise the phenotypes of chronic cough.

Methods

Adult patients with chronic cough were assessed based on the characteristics and severity of their cough using the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionnaire. A cluster analysis was performed using the K-prototype, and the variables to be included were determined using a correlation network.

Results

In total, 255 participants were included in the analysis. Based on the correlation network, age, score for each item, and total COAT score were selected for the cluster analysis. Four clusters were identified and characterised as follows: 1) elderly with mild cough, 2) middle-aged with less severe cough, 3) relatively male-predominant youth with severe cough, and 4) female-predominant elderly with severe cough. All clusters had distinct demographic and symptomatic characteristics and underlying causes.

Conclusions

Cluster analysis of age, score for each item, and total COAT score identified 4 distinct phenotypes of chronic cough with significant differences in the aetiologies. Subgrouping patients with chronic cough into homogenous phenotypes could provide a stratified medical approach for individualising diagnostic and therapeutic strategies.

Introduction

Cough is one of the most common symptoms of pulmonary and extra-pulmonary diseases, leading patients to seek medical attention [1, 2]. The most common causes of chronic cough are known as upper airway cough syndrome (UACS), cough variant asthma (CVA), eosinophilic bronchitis (EB), and gastroesophageal reflux disease (GERD) [36]. However, the associated symptoms of chronic cough vary widely, and determining the aetiology of chronic cough is a difficult process as it can develop for various reasons [711]. Guidelines for the evaluation of chronic cough include a variety of specialized equipment that is impractical for many primary care centres due to limited resources [36]. Furthermore, the pathogenesis of this heterogeneity has not been fully established. Defining the subtypes of these heterogeneous phenotypes of chronic cough is important for better understanding the mechanisms of disease development and progression. Cluster analysis is an unsupervised machine-learning approach used to define specific phenotypes. This analysis has been employed for diverse diseases, including chronic obstructive pulmonary disease [12], congestive heart failure [13], and sepsis [14].

This study aimed to identify the specific subtypes of patients with chronic cough through cluster analysis. We hypothesised that the demographic and clinical signs of the patients would reflect the aetiology of chronic cough. To select the variables to be included in the cluster analysis, we initially searched for features associated with the causes of chronic cough using a correlation matrix. Thereafter, we used K-prototype clustering to categorise the phenotypes of patients with chronic cough and compare their demographics, symptoms, and causes between the clusters. Patients’ symptoms and their severities were measured using the COugh Assessment Test (COAT) [15] and the Korean version of the Leicester Cough Questionnaire (K-LCQ) [16, 17].

Materials and methods

Study participants and ethics

Adult patients (≥ 18 years old) with chronic cough lasting > 8 weeks were recruited from 16 respiratory centres in South Korea. All potential participants were enrolled between December 2016 and July 2017. The cause of chronic cough was assessed following the Korean cough guideline [18] by pulmonary specialists in each hospital, excluding those for patients with suspected abnormalities on plain chest radiography/computed tomography, or with chronic respiratory disease, such as overt asthma, COPD, bronchiectasis, tuberculosis-destroyed lung, and lung cancer. The enrolled participants completed both the COAT [15] and K-LCQ [16, 17] questionnaires at their first visit.

The COAT is a simplified version of the K-LCQ and is used to assess the severity of the cough. It consists of five factors: frequency of the cough (COAT 1), limitation of daily activities (COAT 2), sleep disturbance (COAT 3), fatigue (COAT 4), and hypersensitivity to irritants (COAT 5). All factors were scored on a single scale of 0–4 (total scores of 0–20), where a higher score indicates a more severe cough. We defined cough severity as mild, less severe, and severe if COAT scores corresponded to the first, second, and third to fourth quartiles, respectively. The K-LCQ is a validated cough-specific questionnaire for quality of life, containing 19 questions about physical, psychological, and social domains. A 7-point Likert scale was used for each question (range of 1–7), then mean values for each domain were calculated (scores of 1–7 for each domain), and the total scores were produced by summation of each domain with range of 3–21; higher score indicates a better quality of life. The physical domain is composed of questions regarding chest/stomach pain accompanied by bothersome phlegm, fatigue, hypersensitivity to irritants, sleep disturbances, frequency of coughing bouts, voice hoarseness, and loss of energy. In the psychological domain, questions regarding feeling discontent, worrying about serious illness, and concerns regarding what other people may think were included. The social domain includes questions regarding interference with jobs or daily tasks, life enjoyment, interruption of telephone conversations, and annoyance of partners, family, or friends. Consequently, the K-LCQ and COAT scores were highly associated with a negative correlation [6]. This study was conducted in accordance with the Declaration of Helsinki, and the institutional review board (IRB) of Inje University Ilsan Paik Hospital approved the study protocol (IRB No. ISPAIK 2017-12-025) and waived the need for informed consent as none of the patients were at risk.

Statistical analysis

Patient characteristics were presented as the mean and standard deviation for continuous variables and as relative frequencies for categorical variables. A student’s t-test was used to compare the two groups for continuous response variables such as age, COAT, and K-LCQ scores. For comparison between two categorical variables such as sex and comorbidities, the chi-squared test was used. All statistical analyses were performed using R Project software (version 3.6.0, https://www.r-project.org/). Correlation matrix was drawn for Pearson’s r coefficient using the corrplot package (https://cran.r-project.org/web/packages/corrplot). Cluster analysis was performed using K-prototype clustering, including age, sex, and scores for COAT questions 1–5 and total COAT scores, which contributed to the specific cough phenotype in the correlation matrix and network. Continuous variables were assessed using a standard scale. The K-prototype was constructed using the clustMixType software package (https://cran.r-project.org/web/packages/clustMixType). The optimal number of clusters was selected based on average silhouette width. The silhouette value reflects how similar it is to its own cluster (cohesion) compared with other clusters (separation). The silhouette width was based on the pairwise difference of distances between and within the cluster to validate the performance of clustering. The optimal number of clusters was defined as when the index reached its maximum [19]. The value of the silhouette width was measured using the cluster R package. Finally, the consistency and reliability of clustering outcomes were evaluated based on the random forest classification model with 10-fold cross-validation.

Results

Baseline characteristics

A total of 255 patients with chronic cough (mean age, 47.7 ± 14.3 years) who completed both questionnaires with necessary diagnostic work-up were enrolled from 16 respiratory centres. Among them, 94 (36.9%) men and 161 (63.1%) women were included, with a male-to-female ratio of 1:1.71. The mean duration of cough was 18.3 ± 18.4 weeks. The mean score of the COAT was 11.3 ± 4.1 and that of the K-LCQ was 11.2 ± 3.1. The histogram of the COAT score is drawn in S1 Fig. As the causes of chronic cough, 116 patients (45.5%) were diagnosed with upper airway cough syndrome, 66 (25.9%) with asthma/cough-variant asthma (CVA), 41 (16.1%) with eosinophilic bronchitis, and 34 (13.3%) with gastroesophageal reflux disease (GERD) (S2A Fig). In 16 (6.3%) patients, the cause could not be identified, and a total of 20 participants (7.8%) had multiple causes for their cough (S2B Fig).

Correlation matrix

To understand the correlations between demographics, characteristics, and the severity and aetiologies of chronic cough, correlation matrices for COAT and K-LCQ scores were calculated (S1 Table). Since the COAT scores showed similar correlations with the causes of chronic cough compared to the K-LCQ scores, the COAT score was chosen as a variable for further analysis instead of the K-LCQ score because of its simple application in clinical practice. A correlation matrix (Fig 1) was created using the demographics and COAT scores, and only statistically significant correlations were drawn. Age was negatively correlated with the COAT scores for questions 1–5 and the total COAT scores, but female sex was positively associated with the COAT scores for question 4 and the presence of asthma/CVA. The presence of asthma/CVA was positively correlated with female sex and the COAT scores for questions 3 and 4. The presence of GERD was negatively associated with the COAT scores for questions 2–5 and the total scores. The scores for each question of the COAT were closely correlated with each other.

Fig 1. Correlation matrix for COAT score and aetiologies of chronic cough.

Fig 1

Pearson’s correlation between variables was performed. The intensity of the colour correlates with the strength of the association. Blue indicates positive correlation and red indicates negative correlation. COAT 1: frequency of cough, COAT 2: limitation of daily activities, COAT 3: sleep disturbance, COAT 4: fatigue, COAT 5: hypersensitivity to irritants.

Cluster analysis

Age, sex, COAT scores for questions 1–5, and total COAT scores were selected for cluster analysis based on the correlation matrix. Four clusters were determined using silhouette width (S3 Fig). The distribution of each cluster by age and total COAT score as well as a 3-dimensional plot including K-LCQ scores are shown in Fig 2A and 2B. Advanced age was negatively correlated with the total COAT score in the overall sample (coefficient = -0.07, P < 0.001); however, this significance was not found within each cluster (S4 Fig). The differences in characteristics between the 4 clusters are compared in Table 1 and S2 Table. The duration of the cough did not differ between these clusters.

Fig 2. Distribution of each of the 4 clusters by age and COAT score (A) and a 3-dimensional plot including the K-LCQ score (B).

Fig 2

(A) X and Y axis mean age and COAT total score (B) X, Y, Z axis mean K-LCQ, age, and COAT score, respectively. Cluster analysis was performed by the K-prototype clustering using the clustMixType package. Different colour indicates each cluster (black: cluster 1, red: cluster 2, green: cluster 3, and blue: cluster 4).

Table 1. Baseline characteristics of the entire study population and that compared between clusters of patients with chronic cough.

Total Cluster 1 Cluster 2 Cluster 3 Cluster 4
(N = 255) (N = 44) (N = 67) (N = 81) (N = 63)
Demographics
 Age 47.7 ± 14.3 61.0 ± 11.1 41.3 ± 11.1* 36.3 ± 7.4* 60.1 ± 7.2
 Female sex 161 (63.1%) 28 (63.6%) 37 (55.2%) 43 (53.1%) 53 (84.1%)*
 Current smoker 15 (5.9%) 3 (6.8%) 5 (7.5%) 5 (6.2%) 2 (3.2%)
 Duration (week) 18.3 ± 18.4 14.8 ± 11.7 19.2 ± 23.6 16.2 ± 12.4 24.3 ± 22.3
Cough severity
COAT total 11.3 ± 4.1 5.3 ± 2.1 8.9 ± 1.7* 14.7 ± 2.0* 13.8 ± 2.1*
 COAT 1 2.6 ± 0.8 1.6 ± 0.8 2.2 ± 0.7 3.2 ± 0.4* 2.9 ± 0.5*
 COAT 2 2.2 ± 1.1 0.7 ± 0.7 1.9 ± 0.7* 2.9 ± 0.7* 2.6 ± 0.7*
 COAT 3 1.7 ± 1.2 0.8 ± 1.0 1.0 ± 0.9 2.3 ± 1.1* 2.5 ± 0.9*
 COAT 4 2.0 ± 1.2 0.5 ± 0.7 1.3 ± 0.8* 2.9 ± 0.6* 2.6 ± 0.9*
 COAT 5 2.8 ± 1.0 1.6 ± 1.0 2.4 ± 0.8 3.4 ± 0.7* 3.1 ± 0.8*
K-LCQ total 11.2 ± 3.1 14.5 ± 2.8 12.7 ± 2.3* 9.2± 1.9* 9.7 ± 2.7*
 Physical 4.1 ± 0.9 4.9 ± 1.0 4.5 ± 0.7* 3.6 ± 0.6* 3.6 ± 0.9*
 Psychological 3.5 ± 1.2 4.6 ± 1.0 4.0 ± 1.0* 2.8 ± 0.8* 3.0 ± 1.0*
 Social 3.6 ± 1.3 5.0 ± 1.1 4.2 ± 1.0* 2.8 ± 0.9* 3.1 ± 1.2*
Cough NRA 6.0 ± 2.2 3.5 ± 1.8 5.2 ± 1.8* 7.4 ± 1.6* 6.9 ± 1.7*
Diagnosis
 UACS 116 (45.5%) 17 (38.6%) 30 (44.8%) 39 (48.1%) 30 (47.6%)
 Asthma/CVA 66 (25.9%) 9 (20.5%) 9 (13.4%)* 24 (29.6%) 24 (38.1%)*
 EB 41 (16.1%) 9 (20.5%) 13 (19.4%) 13 (16.0%) 6 (9.5%)
 GERD 34 (13.3%) 11 (25.0%) 14 (20.9%) 6 (7.4%)* 3 (4.8%)*
 Idiopathic cough 16 (6.3%) 2 (4.5%) 6 (9.0%) 3 (3.7%) 5 (7.9%)
 Multiple cause 20 (7.8%) 4 (9.1%) 4 (6.0%) 6 (7.4%) 6 (9.5%)

* Indicates statistical significance compared to Cluster 1 as the reference group

COAT, cough assessment test; LCQ, Leicester cough questionnaire; NRS, numeric rating scale; UACS, upper airway cough syndrome; CVA, cough variant asthma; EB, eosinophilic bronchitis; GERD, gastroesophageal reflux disease

COAT 1: frequency of cough, COAT 2: limitation of daily activities, COAT 3: sleep disturbance, COAT 4: fatigue, COAT 5: hypersensitivity to irritants

Clusters were designated as follows: 1) elderly with mild cough, 2) middle-aged with less severe cough, 3) relatively male-predominant youth with severe cough, and 4) female-predominant elderly with severe cough (Fig 3). The radar charts comparing the patterns of each COAT question for each cluster are summarised in Fig 4. The proportions of each cause of chronic cough according to cluster are summarised in Fig 5. Random forest analysis with 10-fold cross-validation was technically performed to validate the consistency of the clustering results. The accuracies for each cluster 1–4 were 0.980 (SD: 0.031), 0.975 (0.037), 0.994 (0.018), and 0.985 (SD: 0.026), respectively. Overall, the average accuracy was 0.973 (SD: 0.026), suggesting that clustering results were highly consistent.

Fig 3. Summary of baseline characteristics, cough severities, and aetiologies among clusters.

Fig 3

COAT, cough assessment test; K-LCQ, Korean version of Leicester cough questionnaire; CVA, cough variant asthma; GERD, gastroesophageal reflux disease.

Fig 4. Summary of COAT scores among clusters.

Fig 4

COAT 1: Frequency of cough, COAT 2: Limitation on daily activities, COAT 3: Sleep disturbance, COAT 4: Fatigue, COAT 5: Hypersensitivity to irritants.

Fig 5. Proportion of each cause according to clusters.

Fig 5

* Indicates statistical significance. Y axis means proportion of each etiology according to clusters (X axis). UACS, upper airway cough syndrome; CVA, cough variant asthma; EB, eosinophilic bronchitis; GERD, gastroesophageal reflux disease.

Cluster 1: Elderly with mild cough

Cluster 1 represented 17.3% (44/255) of the participants and consisted of elderly patients. Symptoms of cough were mildest, as the total COAT scores and scores for each question were the lowest, and all question scores for the K-LCQ were the highest. The proportion of patients with GERD was higher in cluster 1 than in the other clusters.

Cluster 2: Middle-aged with less severe cough

Cluster 2 represented 26.3% (67/255) of the participants and included a wide range of age groups, with middle-aged mean values. The total COAT scores and scores for each question were less severe than those of cluster 3 or 4, but more severe than those of cluster 1. Total K-LCQ scores and scores for each of its domains showed a similar pattern to that of the COAT scores. The scores for each question of the K-LCQ, except for questions 1, 2, 15, 16, and 17, were higher than the average K-LCQ scores. The proportion of asthma/CVA patients was the lowest in cluster 2.

Cluster 3: Relatively male-predominant youth with severe cough

Cluster 3 represented 31.8% (81/255) of the participants and comprised the youngest population. Although less than 50%, the proportion of men (46.9%) was the highest, and the total COAT scores and the scores for each COAT question were the highest. The total K-LCQ scores and scores for each K-LCQ domain were the lowest in this cluster. All questions of the K-LCQ, except question 9, had the lowest scores in cluster 3. The proportion of GERD patients was lower than cluster 1.

Cluster 4: Female-predominant elderly with severe cough

Cluster 4 represented 24.7% (63/255) of the participants and consist of elderly patients. The proportion of female patients was the highest in this cluster. The total COAT and K-LCQ scores were the most severe, similar to cluster 3. However, unlike cluster 3, the proportion of asthma/CVA was the highest, whereas that of GERD was the lowest in cluster 4.

Discussion

We categorised the heterogeneous population with chronic cough into 4 clusters based on demographics, characteristics, and severity of the cough: elderly with mild cough, middle-aged with less severe cough, relatively male-predominant youth with severe cough, and female-predominant elderly with severe cough. We found that patients within each cluster exhibited varying characteristics and underlying diseases. These findings confirm the existence of heterogeneity in chronic cough and the need for improved phenotyping methods.

Although the mean age was not significantly different between each cause, age has been suggested as one of the important variables in dividing patients by aetiology of cough [20]. An increase in age was negatively correlated with the total COAT score in the overall sample; however, there was no such correlation within each cluster. Decrease in subjective perception of cough severity with increasing age suggests the possible influence of age on cough generation or perception. Female sex was positively associated with the score for COAT question 4 and the presence of asthma/CVA. Cough symptoms were the most severe in the asthma/CVA group but the mildest in the GERD group. However, the cough duration was not a distinct phenotype.

Cluster 1 consisted of the oldest population but showed the least severe cough. In this cluster, GERD contributed to a higher proportion of the underlying causes of cough than in the others. Cluster 2 was composed of a wide range of ages with medium cough severity and a middle-aged mean age value. This cluster had the lowest proportion of asthma/CVA cases. Although both cluster 3 and 4 consisted of patients with the most severe cough, different patterns in demographics and underlying diseases were observed. Cluster 3 had the youngest age group with relative male predominance; in contrast, cluster 4 was the oldest group, with female predominance. Additionally, the proportion of underlying diseases for cough was significantly different, since cluster 4 demonstrated the highest proportion of patients with asthma/CVA and the lowest proportion of those with GERD. Patients with chronic cough in cluster 4 need additional attention due to the high prevalence of asthma/CVA, and rapid diagnosis and treatment are required to prevent disease progression. Meanwhile, more empirical therapeutic trials for proton pump inhibitors could be applied to cluster 1 patients. These clusters could assist clinicians’ decisions by categorising patients to predict underlying causes and indicate further required diagnostic procedures.

The prevalence of GERD was highest in cluster 1 (elderly with mild cough) and lowest in cluster 4 (female-predominant elderly with severe cough). Asthma was prevalent in cluster 4, but less prevalent in cluster 2 (middle-aged with less severe cough). The co-existence of GERD and asthma had been frequently reported [21, 22]. The prevalence of GERD is 21% in mild-to-moderate asthma, while it ranges from 46% to 63% in severe asthma [23]. It was suggested that negative pressure generated by airway obstruction may increase the pressure gradient between the chest and abdomen and provoke reflux. On the other hand, GERD can worsen asthma symptoms by aggravating airway hypersensitivity through aspiration-induced inflammation. Despite their accompaniment, we could see distinct pattern of clustering those diseases, which could help to differentiate the aetiology and understand the detailed pathophysiology of diseases. Moreover, patients with GERD reported less severe cough. One of our hypotheses is that typical GERD-related coughs tend to be periodic, such as coughing at night or after meals, so that the overall mean cough severity may be less severe than in diseases with persistent inflammation of the respiratory tract.

Cluster 3 (relatively male-predominant youth with severe cough) presented similar distribution of underlying causes with the total population. Since age and cough severity are different between each aetiology, characteristics of the common aetiology in each cluster could represent the characteristics of clusters. However, cluster 3 presented similar prevalence of diseases with the total population and could be used as an index group reflecting the characteristics of the general population with chronic cough rather than those of group with specific underlying diseases.

One strength of our study was that we described the characteristics of cough using a standard cough questionnaire measured quantitatively and utilised the results to categorise patients objectively. Moreover, clinicians could easily categorise patients into clusters in clinical practice, due to the simplicity of the COAT questionnaire. Furthermore, these data were collected by pulmonologists from respiratory centres of academic teaching hospitals, especially those who specialise in chronic cough, following the guidelines for diagnosis and treatment of the condition. Therefore, the diagnosis of the underlying causes is reliable, with a low possibility of misdiagnosis.

This analysis demonstrates a novel finding regarding the subtyping of chronic cough. However, there are several limitations. Although these data were collected by respiratory specialists from academic teaching hospitals, detailed results of physical examination, spirometry, bronchoprovocation tests, eosinophil counts in induced sputum and blood, or exhaled fractions of nitric oxide were not collected; therefore, analysis was limited. Body mass index also plays a role in the pathophysiology of several diseases; however, we could not include that information in our analysis due to the lack of dataset. Though we followed the Korean cough guideline in diagnosis of aetiology, there could be bias caused by different manners between different respiratory centres. The number of patients included for clustering was relatively small, which might have diminished the significance between clusters. Furthermore, we had to fill out large number of questionnaires, so considerable number of patients were excluded because of incomplete data collection. Clustering was evaluated only in one country and would need to be validated to further generalise our results. Further large-scale studies are needed to confirm our findings, especially in different countries and ethnicities. Since we did not gather prognostic data, such as treatment success or recurrence, longitudinal studies using clustering methods are required to evaluate the implications of clusters. Lastly, distinct differences in UACS or EB in each cluster were not observed, and additional methods to specify these differences are required.

In conclusion, cluster analysis using demographics and the characteristics of cough categorised four distinct phenotypes of patients with chronic cough. Patients within each cluster varied considerably in terms of symptoms, severity, and underlying causes. Subgrouping patients with chronic cough into homogenous phenotypes could provide a stratified medical approach for individualising diagnostic and therapeutic strategies. Further studies are needed to validate these results.

Supporting information

S1 Table. Correlation matrix of each aetiology with COAT (A) and K-LCQ (B) scores.

(DOCX)

S2 Table. Detailed K-LCQ scores among clusters in patients with chronic cough.

(DOCX)

S1 Fig. Histogram of COAT questionnaire.

(DOCX)

S2 Fig. Prevalence of causes of chronic cough (A) and Venn Diagram (B).

(DOCX)

S3 Fig. Plots of silhouette width according to cluster number.

(DOCX)

S4 Fig. Distribution of each cluster and their correlations between age and COAT score.

(DOCX)

S1 Data

(ZIP)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

This work was supported by the National Research Foundation of Korea (NIRF) grant funded by the Korean government (MIST: No. 2021R1G1A1095110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Mello CJ, Irwin RS, Curley FJ. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med. 1996; 156:997–1003 [PubMed] [Google Scholar]
  • 2.French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 1998; 158:1657–61 doi: 10.1001/archinte.158.15.1657 [DOI] [PubMed] [Google Scholar]
  • 3.Palombini BC. Villanova CA, Araújo E, Gastal OL, Alt DC, Stolz DP, et al. A pathogenic triad in chronic cough: Asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest. 1999; 116:279–284 doi: 10.1378/chest.116.2.279 [DOI] [PubMed] [Google Scholar]
  • 4.Irwin RS. Baumann MH, Bosler DC, Boulet LP, Braman SS, Brightling CE, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl):1S–23S doi: 10.1378/chest.129.1_suppl.1S [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Morice AH, McGarvey L, Pavord I & British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax. 2006; 61(Suppl 1):1–24 doi: 10.1136/thx.2006.065144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: The spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis. 1981; 123:413–417 doi: 10.1164/arrd.1981.123.4.413 [DOI] [PubMed] [Google Scholar]
  • 7.Irwin RS, Curley FJ, French CL. Chronic cough: The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis. 1990; 141:640–647 [DOI] [PubMed] [Google Scholar]
  • 8.Pratter MR. Bartter T, Akers S, DuBois J. An algorithmic approach to chronic cough. Ann Intern Med. 1993; 119:977–983 (1993). doi: 10.7326/0003-4819-119-10-199311150-00003 [DOI] [PubMed] [Google Scholar]
  • 9.Poe R. H. Harder RV, Israel RH, Kallay MC. Chronic persistent cough: Experience in diagnosis and outcome using an anatomic diagnostic protocol. Chest. 1989; 95:723–728 [DOI] [PubMed] [Google Scholar]
  • 10.Smyrnios NA, Irwin RS, Curley FJ. Chronic cough with a history of excessive sputum production: The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest. 1995; 108:991–997 [DOI] [PubMed] [Google Scholar]
  • 11.McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax. 1998; 53:738–743 doi: 10.1136/thx.53.9.738 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy. 2005; 35:1254–1262 doi: 10.1111/j.1365-2222.2005.02344.x [DOI] [PubMed] [Google Scholar]
  • 13.Ahmad T, Pencina MJ, Schulte PJ, O’Brien E, Whellan DJ, Pina IL, et al. Clinical implications of chronic heart failure phenotypes defined by cluster analysis. J Am Coll Cardiol. 2014;64:1765–74. doi: 10.1016/j.jacc.2014.07.979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Guilamet MCV, Bernauer M, Micek ST, Kollef MH. Cluster analysis to define distinct clinical phenotypes among septic patients with bloodstream infections. Medicine (Baltimore). 2019;98:e15276. doi: 10.1097/MD.0000000000015276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Koo HK, Jeong I, Kim JH, Kim SK, Shin JW, Park SY, et al. Cough Study Group of the Korean Academy of Tuberculosis and Respiratory Diseases. Development and validation of the COugh Assessment Test (COAT). Respirology. 2019;24(6):551–557 [DOI] [PubMed] [Google Scholar]
  • 16.Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003; 58(4):339–43 doi: 10.1136/thorax.58.4.339 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kwon JW, Moon JY, Kim SH, Song WJ, Kim MH, Kang MG, et al. Work Group for Chronic Cough, the Korean Academy of Asthma, Allergy and Clinical Immunology. Korean version of the Cough Symptom Score: clinical utility and validity for chronic cough. Korean J Intern Med. 2017; 32(5):910–915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rhee CK, Jung JY, Lee SW, Kim JH, Park SY, Yoo KH, et al. The Korean Cough Guideline: Recommendation and Summary Statement. Tuberc Respir Dis (Seoul). 2016; 79:14–21 doi: 10.4046/trd.2016.79.1.14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rousseeuw PJ. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. Journal of Computational and Applied Mathematics. 1987;20:53–65. [Google Scholar]
  • 20.Koo HK, Bae W, Moon JY, Lee H, Kim JW, Jang SH, et al. Differential features of chronic cough according to etiology and the simple decision tree for predicting causes. Sci Rep. 2021. May 14;11(1):10326 doi: 10.1038/s41598-021-89741-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cazzola M, Segreti A, Calzetta L, Rogliani P. Comorbidities of asthma: current knowledge and future research needs. Curr Opin Pulm Med. 2013; 19: 36–41. doi: 10.1097/MCP.0b013e32835b113a [DOI] [PubMed] [Google Scholar]
  • 22.Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, et al. Clinical and inflammatory characteristics of the European U‑BIOPRED adult severe asthma cohort. Eur Respir J. 2015; 46: 1308–1321. doi: 10.1183/13993003.00779-2015 [DOI] [PubMed] [Google Scholar]
  • 23.Rogliani P, Sforza M, Calzetta L. The impact of comorbidities on severe asthma. Curr Opin Pulm Med. 2020; 26: 47–55. doi: 10.1097/MCP.0000000000000640 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Bharat Bhushan Sharma

26 Dec 2022

PONE-D-22-25031Clinical Phenotypes of Chronic Cough Categorised by Cluster AnalysisPLOS ONE

Dear Dr. Koo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

ACADEMIC EDITOR:

Further clarification is necessary regarding individual components of cough clusters and why it is important to divide cough into the clusters identified by the authors in the manuscript.

Do you think that your findings challenge current thinking about cough as a clinical symptom? The evidence presented must be strong enough to prove your case. Try to cite all the relevant work that would contradict your thinking and address it appropriately.

Please submit your revised manuscript by Feb 09 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Bharat Bhushan Sharma, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

Additional Editor Comments:

The manuscript has been reviewed by a set of reviewers.

Further clarification is necessary regarding individual components of cough clusters and why it is important to divide cough into the clusters identified by the authors in the manuscript.

Do you think that your findings challenge current thinking about cough as a clinical symptom? The evidence presented must be strong enough to prove your case. Try to cite all the relevant work that would contradict your thinking and address it appropriately.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Following up you arguments was a little challenging it would be better that you clear delineate the cough assessment and clustering. From table 1 female predominate all groups but this is not reflected in the text. There is some attempt to link clustering with etiology but other than Asthma/CVA and GERD its not claear if other clustering predicted cause.

This is a good start as the world is moving to ML and AI

Reviewer #2: This manuscript by Kang et al. focused on the clinical phenotypes of chronic cough. Authors evaluated the characteristics and severity of chronic cough using the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionnaire (K-LCQ) and categorized patients with chronic cough into 4 clusters using the cluster analysis. As authors mentioned, etiology of cough and underlying diseases in patients with chronic cough are various. Therefore, the concept of this study to clarify the characteristics of these patients is valuable and results seem agreeable. Although this manuscript seems written well, authors may want to consider several issues as follows.

Major comments

1) It is difficult to understand why the etiology of chronic cough was diagnosed only 4 diseases such as upper airway cough syndrome (UACS), asthma/cough variant asthma (CVA), eosinophilic bronchitis (EB), and gastroesophageal reflux disease (GERD). How did authors deal with other respiratory diseases such as interstitial pneumonia, COPD, and lung cancer? Were these diseases included in UACS? Otherwise, authors should clarify what diseases are included in UACS.

2) In relation to above, although only GERD was listed as an extra pulmonary cause of chronic cough, how did authors categorize other diseases such as chronic sinusitis and congestive heart failure.

3) It is unknown whether this clustering was associated with any outcome in patients with chronic cough from this study.

Minor comments

1) Number of patients seems relatively small to identify clusters.

2) In Table 1, “current smoker” is duplicated and is not a diagnosis. In addition, what does “idiopathic” mean? Is this same as “unknown cause”?

3) In Table 1, If so, its number may be 19 as described in the main text. Furthermore, according to the Supplementary Figure S2B, number of multiple cause should be 20. Please make sure all numbers carefully again.

4) In Table 1, for what dis asterisk indicate statistical significance? Comparison should be performed among 4 clusters.

Reviewer #3: In the manuscript, the authors tried to categorise the phenotypes of chronic cough by cluster analy based on the characteristics and severity of cough assessed by the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionnaire. They found chronic cough could be divided into four cluster pehenotypes: 1) elderly with mild cough, 2) middle-aged with less severe cough, 3) relatively male-predominant youth with severe cough, and 4) female-predominant elderly with severe cough. All clusters had distinct demographic and symptomatic characteristics and underlying causes. They concluded four distinct phenotypes of chronic cough reflected the significant differences in the aetiologies and provided a stratified medical approach for individualising diagnostic and therapeutic strategies. It is an interesting research. However, there are several isssus to be addressed.

Major comments

1.Four cough phenotypes were clustered based on the simple characteristics and simple tools of cough evaluation tool, and may reflect some feature of common etiologies underlying chronic cough. However, the common causes of chronic cough can be easily identified and management following the current approach for chronic cough. Do we really need these cluster phenotypes since their identification seems to have no potential ability to improve the diagonosis and treatment of these common etiologies?

2.In the cohort of the patients with chronic cough, there were 19 (6.3%) patients whose cause was not identified and 20 participants (7.8%) who had multiple causes for their cough. What about their distribution in four cluster phenotypes? I think it may help to seek specific therapy if the phenotypes of these chronic refractory cough can be identified by the cluster analysis because their management is difficult and challenging.

.

The minor comments

1.Cluster 1 had a mild cough and older age with GERD as a main underlying etiology. Please explain why GERD-associated cough coughed mildly.

2.It is a surprise that age was negatively correlated with the COAT scores for questions 1-5 and the total COAT.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr Evans Amukoye

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Clinical Phenotypes of Chronic Cough Categorised by Cluster Analysis.docx

PLoS One. 2023 Mar 17;18(3):e0283352. doi: 10.1371/journal.pone.0283352.r002

Author response to Decision Letter 0


24 Jan 2023

Additional Editor Comments:

The manuscript has been reviewed by a set of reviewers.

Further clarification is necessary regarding individual components of cough clusters and why it is important to divide cough into the clusters identified by the authors in the manuscript.

Do you think that your findings challenge current thinking about cough as a clinical symptom? The evidence presented must be strong enough to prove your case. Try to cite all the relevant work that would contradict your thinking and address it appropriately.

Answer: Thank you for your comment. Cough is the most prevalent symptom of numerous diseases, including pulmonary and extra-pulmonary diseases. In addition, cough-related symptoms are highly variable, making it quite difficult to determine the underlying cause. Furthermore, guidelines for chronic cough evaluation require a variety of specialized equipment that is impractical for many primary care centers with limited resources, thereby increasing the difficulty for physicians. Due to these challenges, some guidelines also recommend empirical treatment for potential causes first, followed by re-evaluation of treatment response as an alternative strategy. Therefore, identifying the subtypes of these heterogeneous phenotypes of chronic cough is crucial for better understanding of the pathophysiology and treatment of disease. So far, the majority of research on chronic cough had primarily focused on epidemiology and diagnostic flow. Few studies had described phenotypes and compared differences according to etiology. The aim of our study was to identify specific subtypes using cluster analysis in order to assist physicians in diagnosing the cause of chronic cough based on the phenotypes of heterogeneous patients.  

Reviewers' comments:

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Following up you arguments was a little challenging it would be better that you clear delineate the cough assessment and clustering. From table 1 female predominate all groups but this is not reflected in the text. There is some attempt to link clustering with etiology but other than Asthma/CVA and GERD its not clear if other clustering predicted cause.

This is a good start as the world is moving to ML and AI

Answer: Thank you very much for your comments. As you pointed, proportion of females in all clusters was greater than fifty percent, which is usual pattern for chronic cough population. We added the following sentences to the Result section to clarify the predominance of females.

(Page 9, line 141) Among them, 94 (36.9%) men and 161 (63.1%) women were included, with a male-to-female ratio of 1:1.71.

(Page 12, line 205) Cluster 3 represented 31.8% (81/255) of the participants and comprised the youngest population. Although less than 50%, the proportion of men (46.9%) was the highest, and the total COAT scores and the scores for each COAT question were the highest.

Furthermore, as you pointed, we were unable to identify the specific predominance other than asthma/CVA and GERD. To clarify the facts, we added the following limitation to Discussion section:

(Page 16, Line 296) Lastly, distinct differences of UACS or EB in each cluster were not observed, and additional methods to specify these differences are required.

Reviewer #2: This manuscript by Kang et al. focused on the clinical phenotypes of chronic cough. Authors evaluated the characteristics and severity of chronic cough using the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionnaire (K-LCQ) and categorized patients with chronic cough into 4 clusters using the cluster analysis. As authors mentioned, etiology of cough and underlying diseases in patients with chronic cough are various. Therefore, the concept of this study to clarify the characteristics of these patients is valuable and results seem agreeable. Although this manuscript seems written well, authors may want to consider several issues as follows.

Major comments

1) It is difficult to understand why the etiology of chronic cough was diagnosed only 4 diseases such as upper airway cough syndrome (UACS), asthma/cough variant asthma (CVA), eosinophilic bronchitis (EB), and gastroesophageal reflux disease (GERD). How did authors deal with other respiratory diseases such as interstitial pneumonia, COPD, and lung cancer? Were these diseases included in UACS? Otherwise, authors should clarify what diseases are included in UACS.

Answer: Thank you for your insightful comment. Previous reports have highlighted UACS, asthma including CVA, EB, and GERD as the primary causes of chronic cough in non-smokers with normal chest radiographs. We added the following sentence to the Introduction section:

(Page 4, Line 62) The most common causes of chronic cough are known as upper airway cough syndrome (UACS), cough variant asthma (CVA), eosinophilic bronchitis (EB), and gastroesophageal reflux disease (GERD) [3-6].

We also included patients without structural lung disease in chest X-ray or CT, following the previous definition. We appreciate for allowing us to clarify the inclusion criteria. Inclusion criteria in the Method section were specified as follows:

(Page 6, Line 88) The cause of chronic cough was assessed following the Korean cough guideline [18] by pulmonary specialists in each hospital, excluding those for patients with suspected abnormalities on plain chest radiography/computed tomography or with chronic respiratory disease, such as overt asthma, COPD, bronchiectasis, tuberculosis-destroyed lung, and lung cancer.

2) In relation to above, although only GERD was listed as an extra pulmonary cause of chronic cough, how did authors categorize other diseases such as chronic sinusitis and congestive heart failure.

Answer: Thank you for your points. Chronic sinusitis was categorized as upper airway cough syndrome, while structural diseases with abnormal chest X-ray including heart failure were excluded. Additionally, only patients with chronic cough as the primary reason for hospital visit were enrolled; those with other diseases who primarily complained of other symptoms, such as dyspnea, but cough as a secondary symptom were not enrolled. We clarified the inclusion criteria in the Method section as above mentioned.

(Page 6, Line 88) The cause of chronic cough was assessed following the Korean cough guideline [18] by pulmonary specialists in each hospital, excluding those for patients with suspected abnormalities on plain chest radiography/computed tomography or with chronic respiratory disease, such as overt asthma, COPD, bronchiectasis, tuberculosis-destroyed lung, and lung cancer.

3) It is unknown whether this clustering was associated with any outcome in patients with chronic cough from this study.

Answer: Thank you for your comments. As you pointed, we did not collect prognostic data, and the lack of longitudinal data, such as treatment success, recurrence, or even death, is one of our study’s significant limitations. This limitation was outlined in the Discussion section. We modified this sentence further to specify the outcomes as follows:

(Page 16, Line 294) Since we did not gather prognostic data, such as treatment success or recurrence, longitudinal studies using clustering methods are required to evaluate the implications of clusters.

Minor comments

1) Number of patients seems relatively small to identify clusters.

Answer: Thank you for your points. That is correct. We added that limitation to the Discussion section as follows:

(Page 16, Line 288) The number of patients included for clustering was relatively small, which might have diminished the significance between clusters.

2) In Table 1, “current smoker” is duplicated and is not a diagnosis. In addition, what does “idiopathic” mean? Is this same as “unknown cause”?

Answer: Thank you very much for allowing us the opportunity to correct our error. The duplicated smoking variable was eliminated from Table 1. According to the ACCP guideline (Unexplained (idiopathic) cough: ACCP evidence-based clinical practice guidelines. Chest 2006 Jan;129(1 Suppl):220S-221S), idiopathic or unexplained cough was defined as a cough with no etiology identified after evaluation, also known as an unknown cause. To specify the cause, we changed the term ‘idiopathic’ to ‘idiopathic cough’ in Table 1.

3) In Table 1, If so, its number may be 19 as described in the main text. Furthermore, according to the Supplementary Figure S2B, number of multiple cause should be 20. Please make sure all numbers carefully again.

Answer: Thank you very much for thorough review and suggestions. We sincerely appreciate the opportunity to correct our error. As you pointed, the exact number of patients with multiple causes is 20 and those with idiopathic cough is 16. Changes are made to the numbers in the Result section and Table 1.

(Page 9, Line 148) In 16 (6.3%) patients, the cause could not be identified and a total of 20 participants (7.8%) had multiple causes for their cough (S2B Fig).

4) In Table 1, for what dis asterisk indicate statistical significance? Comparison should be performed among 4 clusters.

Answer: We greatly appreciate your comment. All comparisons were re-evaluated using cluster 1 as the reference.

Reviewer #3: In the manuscript, the authors tried to categorise the phenotypes of chronic cough by cluster analy based on the characteristics and severity of cough assessed by the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionnaire. They found chronic cough could be divided into four cluster phenotypes: 1) elderly with mild cough, 2) middle-aged with less severe cough, 3) relatively male-predominant youth with severe cough, and 4) female-predominant elderly with severe cough. All clusters had distinct demographic and symptomatic characteristics and underlying causes. They concluded four distinct phenotypes of chronic cough reflected the significant differences in the aetiologies and provided a stratified medical approach for individualising diagnostic and therapeutic strategies. It is an interesting research. However, there are several issues to be addressed.

Major comments

1.Four cough phenotypes were clustered based on the simple characteristics and simple tools of cough evaluation tool, and may reflect some feature of common etiologies underlying chronic cough. However, the common causes of chronic cough can be easily identified and management following the current approach for chronic cough. Do we really need these cluster phenotypes since their identification seems to have no potential ability to improve the diagnosis and treatment of these common etiologies?

Answer: Thank you for your comments. In guideline, algorithm for chronic cough evaluation includes chest radiography, PNS view, spirometry with bronchodilator reversibility test, bronchoprovocation test, induced sputum analysis, FENO, gastro-endoscopy, and for the specific diagnosis, chest CT, PNS CT, bronchoscopy, and echocardiography are additionally required. However, these tests require a variety of specialized laboratory equipment and space, which is not feasible for many primary care centers due to limited resources. Because of these challenges, some guidelines also recommend empirical treatment for potential causes first and subsequent re-evaluating treatment response as an alternative strategy. Therefore, clustering the phenotype would be advantageous for many primary care centers that treat numerous patients with chronic cough. We added the following sentence to the Introduction section:

(Page 4, Line 64) However, the associated symptoms of chronic cough vary widely, and determining the aetiology of chronic cough is a difficult process as it can develop for various reasons [7-11]. Guidelines for the evaluation of chronic cough include a variety of specialized equipment, which is not feasible for many primary care centres due to limited resources [3-6].

2.In the cohort of the patients with chronic cough, there were 19 (6.3%) patients whose cause was not identified and 20 participants (7.8%) who had multiple causes for their cough. What about their distribution in four cluster phenotypes? I think it may help to seek specific therapy if the phenotypes of these chronic refractory cough can be identified by the cluster analysis because their management is difficult and challenging.

Answer: Thank you for your insightful comment. Unfortunately, there were no significant differences in the distribution of these patients between clusters. The numbers and percentages are detailed in Table 1.

The minor comments

1.Cluster 1 had a mild cough and older age with GERD as a main underlying etiology. Please explain why GERD-associated cough coughed mildly.

Answer: Thank you very much for your comment. We were unable to find the reference because trials comparing cough severity in each etiology had not been conducted. One of our potential hypotheses is that typical GERD-related coughs tend to be periodic, such as coughing at night time or after meal, so that the overall mean cough severity may be less severe than in other diseases with persistent respiratory tract inflammation. We added following explanation to the Discussion section:

(Page 14, Line 260) Moreover, patients with GERD reported less severe cough. One of our hypotheses is that typical GERD-related coughs tend to be periodic, such as coughing at night or after meal, so that the overall mean cough severity may be less severe than in diseases with persistent inflammation of respiratory tract.

2. It is a surprise that age was negatively correlated with the COAT scores for questions 1-5 and the total COAT.

Answer: Thank you very much for your comment. We added following sentences to explain the potential mechanism.

(Page 13, Line 228) An increase in age was negatively correlated with the total COAT score in the overall sample; however, there was no such correlation within each cluster. Decrease of subjective perception of cough severity with increasing age suggests the possible influence of age on generation or perception of cough.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Bharat Bhushan Sharma

2 Mar 2023

PONE-D-22-25031R1Clinical phenotypes of chronic cough categorised by cluster analysisPLOS ONE

Dear Dr. Koo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

Please proofread your paper thoroughly and correct spelling, punctuation, grammar, and formatting errors. Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of references is crucial. For more information, please refer to submission guidelines of the journal.

==============================

Please submit your revised manuscript by Apr 16 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Bharat Bhushan Sharma, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please proofread your paper thoroughly and correct spelling, punctuation, grammar, and formatting errors. Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of references is crucial. For more information, please refer to submission guidelines of the journal.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a good start In using data (AI) to predict causes of chronic cough. I note no clustering in certain groups that leaves a lacuna, but as we get more data we may find out if we may/may not cluster all possible groups.

I accept your responses

Reviewer #2: This revised manuscript by Kang et al. focused on the clinical phenotypes of chronic cough. Authors evaluated the characteristics and severity of chronic cough using the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionnaire (K-LCQ) and categorized patients with chronic cough into 4 clusters using the cluster analysis. Authors revised the manuscript appropriately according to the reviewers’ comments. It appeared better. I do not have further comment to be resolved.

Reviewer #3: After revision, the quality of manuscript has greatly been improved. I have no further comments for the revised manuscript that need to be addressed.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 17;18(3):e0283352. doi: 10.1371/journal.pone.0283352.r004

Author response to Decision Letter 1


3 Mar 2023

Thank you very much for allowing us the opportunity to correct our errors. We corrected spelling, punctuation, grammar, and reference formatting errors all through the manuscript. Both tracked and clean versions of the manuscript are provided. Again, we appreciate all the invaluable comments that improved the overall quality of our manuscript.

Attachment

Submitted filename: Response to reviewer_R2.docx

Decision Letter 2

Bharat Bhushan Sharma

7 Mar 2023

Clinical phenotypes of chronic cough categorised by cluster analysis

PONE-D-22-25031R2

Dear Dr. Koo,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Bharat Bhushan Sharma, M.D.

Academic Editor

PLOS ONE

Acceptance letter

Bharat Bhushan Sharma

9 Mar 2023

PONE-D-22-25031R2

Clinical phenotypes of chronic cough categorised by cluster analysis

Dear Dr. Koo:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Bharat Bhushan Sharma

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Correlation matrix of each aetiology with COAT (A) and K-LCQ (B) scores.

    (DOCX)

    S2 Table. Detailed K-LCQ scores among clusters in patients with chronic cough.

    (DOCX)

    S1 Fig. Histogram of COAT questionnaire.

    (DOCX)

    S2 Fig. Prevalence of causes of chronic cough (A) and Venn Diagram (B).

    (DOCX)

    S3 Fig. Plots of silhouette width according to cluster number.

    (DOCX)

    S4 Fig. Distribution of each cluster and their correlations between age and COAT score.

    (DOCX)

    S1 Data

    (ZIP)

    Attachment

    Submitted filename: Clinical Phenotypes of Chronic Cough Categorised by Cluster Analysis.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to reviewer_R2.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES